Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities
University of Leicester · Leicester Royal Infirmary
Abstract
Resveratrol has long been proposed as being beneficial to human health across multiple morbidities, yet there is currently no conclusive clinical evidence to advocate its recommendation in any healthcare setting. A large cohort with high-quality clinical data and clearly defined biomarkers or endpoints are required to draw meaningful conclusions. This systematic review compiles every clinical trial conducted using a defined dose of resveratrol in a purified form across multiple morbidities to highlight the current 'state-of-play' and knowledge gaps, informing future trial designs to facilitate the realisation of resveratrol's potential benefits to human health. Over the last 20 years, there have been almost…
Citation impact
- FWCI
- 42.87
- Percentile
- 100%
- References
- 213
Authors
7- KBKaren BrownCorresponding
University of Leicester, Leicester Royal Infirmary
- DTDespoina Theofanous
University of Leicester, Leicester Royal Infirmary
- RGRobert G. Britton
University of Leicester, Leicester Royal Infirmary
- GAGrandezza Aburido
University of Leicester, Leicester Royal Infirmary
- CPCoral Pepper
Leicester Royal Infirmary
Topics & keywords
- Resveratrol
- Clinical trial
- Medicine
- Disease
- Randomized controlled trial
- Intensive care medicine
- Bioinformatics
- Pharmacology